Daily Archives: January 16, 2019

Fukudo S, Endo Y, Hongo M et al. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomized, placebo-controlled, double-blind phase 2 trial. Lancet Gastroenterol Hepatol 2018;3:603–613. Continue reading →

Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 2018;174:1388–1405. Continue reading →

We would like to thank Liu and colleagues for their letter with regards to our study entitled, “Variation in Interleukin 6 Receptor Gene Associates with Risk of Crohn’s Disease and Ulcerative Colitis.”1 In summary, the additional analysis carried… Continue reading →

We appreciate the opportunity to respond to Dr Weinberg’s comments and to provide additional data to aid clinicians in determining the clinical scenarios where avatrombopag should be considered. Continue reading →